Q3 EPS Estimate for SelectQuote Decreased by Analyst

Key Points

• Noble Financial cut SelectQuote’s Q3 2027 EPS estimate to a loss of $0.02 per share from its prior expectation of $0.01. It also forecasts losses of $0.25 per share for FY2027 and $0.29 for FY2028.
• Analyst opinions are mixed, but SelectQuote has a consensus Hold rating and an average price target of $3.00.
• In its latest quarter, SelectQuote reported a loss of $0.21 per share, beating the consensus estimate of a $0.33 loss; revenue of $280.01 million also exceeded estimates.

SelectQuote, Inc. (NYSE:SLQT - Free Report) - Analysts at Noble Financial dropped their Q3 2027 EPS estimates for SelectQuote in a research report issued on Thursday, November 5th. Noble Financial analyst M. Kupinski now expects that the company will post earnings of ($0.02) per share for the quarter, down from their previous forecast of $0.01. The consensus estimate for SelectQuote's current full-year earnings is ($0.25) per share. Noble Financial also issued estimates for SelectQuote's Q4 2027 earnings at ($0.13) EPS, FY2027 earnings at ($0.25) EPS and FY2028 earnings at ($0.29) EPS.

A number of other brokerages also recently issued reports on SLQT. Zacks Research raised SelectQuote from a "strong sell" rating to a "hold" rating in a research note on Monday, October 26th. Wall Street Zen downgraded SelectQuote from a "hold" rating to a "sell" rating in a research note on Saturday, August 29th. Finally, Weiss Ratings downgraded SelectQuote from a "sell (d+)" rating to a "sell (d)" rating in a research note on Monday, August 17th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $3.00.

SelectQuote Price Performance

Shares of SLQT opened at $0.48 on Monday. SelectQuote has a twelve month low of $0.30 and a twelve month high of $1.76. The stock's 50 day moving average is $0.42 and its two-hundred day moving average is $0.76. The firm has a market capitalization of $86.31 million, a PE ratio of -16.03 and a beta of 2.01. The company has a current ratio of 7.48, a quick ratio of 7.48 and a debt-to-equity ratio of 1.16.

SelectQuote (NYSE:SLQT - Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.33) by $0.12. The business had revenue of $280.01 million for the quarter, compared to analyst estimates of $277.91 million. SelectQuote had a net margin of 4.61% and a return on equity of 22.48%.

Institutional Trading of SelectQuote

Institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new position in SelectQuote during the second quarter worth about $1,836,000. GSA Capital Partners LLP acquired a new stake in shares of SelectQuote during the 2nd quarter valued at approximately $1,123,000. Renaissance Technologies LLC lifted its position in shares of SelectQuote by 817.6% during the 1st quarter. Renaissance Technologies LLC now owns 1,021,239 shares of the company's stock valued at $643,000 after acquiring an additional 909,939 shares during the period. Squarepoint Ops LLC purchased a new stake in shares of SelectQuote during the 2nd quarter worth approximately $536,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of SelectQuote during the 2nd quarter worth approximately $461,000. Hedge funds and other institutional investors own 34.59% of the company's stock.

About SelectQuote

SelectQuote, Inc NYSE: SLQT operates a technology-enabled insurance distribution platform that helps consumers compare and purchase insurance products from third-party carriers. The company combines digital tools, proprietary data and licensed agents to connect customers with coverage suited to their needs.

SelectQuote's primary business is its Senior segment, which provides access to Medicare Advantage, Medicare Supplement and prescription drug plans. The company has also historically offered life insurance, as well as auto and home insurance, through its Life and Auto & Home businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.